Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2017

21.12.2016

Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion

verfasst von: Maria José Franco-Barrera, Maria Guadalupe Zavala-Cerna, Georgina Aguilar-Portillo, Diana Brisa Sánchez-Gomez, Olivia Torres-Bugarin, Miguel Angel Franco-Barrera, Carlos Manuel Roa-Encarnacion

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Gorham-Stout disease (GSD) is a rare condition of osteolysis with excessive lymphangiogenesis within bone tissue. The etiology of this condition remains unknown but seems to affect mainly children and young adults of both genders all over the world. Unfortunately, there is no standardized method for diagnosis; however, histopathology remains as the gold standard. This condition is often misdiagnosed due to its varying clinical presentations from case-to-case. Here, we report the case of an 8-year-old girl who presented with chronic mandibular pain during mastication and received multiple antibiotic treatment due to infectious origin suspicion. After integrating information from clinical manifestations, radiographic, laboratory, and histopathology information, she was diagnosed with GSD. Additionally, due to the lack of literature with respect to insights into biological mechanisms and standardized treatment for this condition, we underwent a literature revision to provide information related to activation of cells from the immune system, such as macrophages, T-cells, and dendritic cells, and their contribution to the lymphangiogenesis, angiogenesis, and osteoclastogenic process in GSD. It is important to consider these mechanisms in patients with GSD, especially since new studies performed in earlier stages are required to confirm their use as novel diagnostic tools and find new possibilities for treatment.
Literatur
1.
Zurück zum Zitat Ellati R et al (2016) Novel approach of treating Gorham-Stout disease in the humerus—case report and review of literature. Eur Rev Med Pharmacol Sci 20(3):426–432PubMed Ellati R et al (2016) Novel approach of treating Gorham-Stout disease in the humerus—case report and review of literature. Eur Rev Med Pharmacol Sci 20(3):426–432PubMed
3.
Zurück zum Zitat Evrenos MK et al (2016) Case report: Gorham-Stoute syndrome with involvement of majority of mandible, and partial maxillary, temporal and zygomatic bones. J Maxillofac Oral Surg 15(Suppl 2):335–338CrossRefPubMed Evrenos MK et al (2016) Case report: Gorham-Stoute syndrome with involvement of majority of mandible, and partial maxillary, temporal and zygomatic bones. J Maxillofac Oral Surg 15(Suppl 2):335–338CrossRefPubMed
4.
Zurück zum Zitat Ruggieri P et al (2011) Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol 40(11):1391–1397CrossRef Ruggieri P et al (2011) Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol 40(11):1391–1397CrossRef
5.
Zurück zum Zitat Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37-A(5):985–1004CrossRefPubMed Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37-A(5):985–1004CrossRefPubMed
6.
Zurück zum Zitat Heffez L et al (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55(4):331–343CrossRefPubMed Heffez L et al (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55(4):331–343CrossRefPubMed
7.
Zurück zum Zitat Kokosis G et al (2016) Mandibular reconstruction using the free vascularized fibula graft: an overview of different modifications. Arch Plast Surg 43(1):3–9CrossRefPubMedPubMedCentral Kokosis G et al (2016) Mandibular reconstruction using the free vascularized fibula graft: an overview of different modifications. Arch Plast Surg 43(1):3–9CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Abdulai A-E et al (2014) Vanishing bone (Gorham’s) disease of the mandible: a case report. Sch J Med Case Rep 2(3):183–187 Abdulai A-E et al (2014) Vanishing bone (Gorham’s) disease of the mandible: a case report. Sch J Med Case Rep 2(3):183–187
9.
Zurück zum Zitat Colucci S et al (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21(2):207–218CrossRefPubMed Colucci S et al (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21(2):207–218CrossRefPubMed
10.
Zurück zum Zitat Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95(4):1469–1504CrossRef Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95(4):1469–1504CrossRef
11.
Zurück zum Zitat Yuan F (2012) Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Mol Biol Rep 39(1):771–774CrossRefPubMed Yuan F (2012) Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Mol Biol Rep 39(1):771–774CrossRefPubMed
12.
Zurück zum Zitat Zavala-Cerna, M.G., et al. (2015) Osteoprotegerin polymorphisms in a Mexican population with rheumatoid arthritis and generalized osteoporosis: a preliminary report. J Immunol Res 376197 Zavala-Cerna, M.G., et al. (2015) Osteoprotegerin polymorphisms in a Mexican population with rheumatoid arthritis and generalized osteoporosis: a preliminary report. J Immunol Res 376197
13.
Zurück zum Zitat D’Amico L, R. I. (2012) Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Reports 1(6) D’Amico L, R. I. (2012) Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Reports 1(6)
14.
Zurück zum Zitat Song I et al (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440CrossRefPubMed Song I et al (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440CrossRefPubMed
15.
Zurück zum Zitat Hirayama T et al (2001) Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195(5):624–630CrossRefPubMed Hirayama T et al (2001) Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195(5):624–630CrossRefPubMed
16.
Zurück zum Zitat Yang X et al (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41(6):928–936CrossRefPubMedPubMedCentral Yang X et al (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41(6):928–936CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81(5):1893–1897PubMed Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81(5):1893–1897PubMed
18.
Zurück zum Zitat Rifas L, Weitzmann MN (2009) A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum 60(11):3324–3335CrossRefPubMedPubMedCentral Rifas L, Weitzmann MN (2009) A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum 60(11):3324–3335CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Jin Z, Li X, Wan Y (2015) Minireview: nuclear receptor regulation of osteoclast and bone remodeling. Mol Endocrinol 29(2):172–186CrossRefPubMed Jin Z, Li X, Wan Y (2015) Minireview: nuclear receptor regulation of osteoclast and bone remodeling. Mol Endocrinol 29(2):172–186CrossRefPubMed
20.
Zurück zum Zitat D'Amelio P et al (2011) Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int 22(11):2869–2877CrossRefPubMed D'Amelio P et al (2011) Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int 22(11):2869–2877CrossRefPubMed
21.
Zurück zum Zitat Pagliari D et al (2015) The role of “bone immunological niche” for a new pathogenetic paradigm of osteoporosis. Anal Cell Pathol (Amst):434389 Pagliari D et al (2015) The role of “bone immunological niche” for a new pathogenetic paradigm of osteoporosis. Anal Cell Pathol (Amst):434389
22.
Zurück zum Zitat Moller G, Priemel M (1999) The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. The Journal of bone and joint surgery British 81(5):1893–1897 Moller G, Priemel M (1999) The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. The Journal of bone and joint surgery British 81(5):1893–1897
23.
24.
Zurück zum Zitat Bonomo A et al (2016) A T cell view of the bone marrow. Front Immunol 17(7):184 Bonomo A et al (2016) A T cell view of the bone marrow. Front Immunol 17(7):184
26.
Zurück zum Zitat Kon T et al (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16(6):1004–1014CrossRefPubMed Kon T et al (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16(6):1004–1014CrossRefPubMed
27.
Zurück zum Zitat Wiemer AJ et al (2011) A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist. J Immunol 187(7):3663–3670CrossRefPubMedPubMedCentral Wiemer AJ et al (2011) A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist. J Immunol 187(7):3663–3670CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Lee SK, Lorenzo J (2006) Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 18(4):411–418CrossRefPubMed Lee SK, Lorenzo J (2006) Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 18(4):411–418CrossRefPubMed
29.
Zurück zum Zitat Franchi A et al (2009) CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 62(2):163–167CrossRefPubMed Franchi A et al (2009) CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 62(2):163–167CrossRefPubMed
30.
Zurück zum Zitat Pettit AR et al (2008) Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43(6):976–982CrossRefPubMed Pettit AR et al (2008) Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43(6):976–982CrossRefPubMed
31.
Zurück zum Zitat Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40B(3):494–501 Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40B(3):494–501
32.
Zurück zum Zitat Ray S et al (2012) Vanishing bone disease (Gorhamʼs disease)—a rare occurrence of unknown etiology. Indian J Pathol Microbiol 55(3):399–401CrossRefPubMed Ray S et al (2012) Vanishing bone disease (Gorhamʼs disease)—a rare occurrence of unknown etiology. Indian J Pathol Microbiol 55(3):399–401CrossRefPubMed
33.
Zurück zum Zitat Fujiu K et al (2002) Chylothorax associated with massive osteolysis (Gorhamʼs syndrome). Ann Thorac Surg 73(6):1956–1957CrossRefPubMed Fujiu K et al (2002) Chylothorax associated with massive osteolysis (Gorhamʼs syndrome). Ann Thorac Surg 73(6):1956–1957CrossRefPubMed
34.
Zurück zum Zitat Bickel WH, Brodere AC (1947) Primary lymphangioma of the ilium; report of a case. J Bone Joint Surg Am 29(2):517–522PubMed Bickel WH, Brodere AC (1947) Primary lymphangioma of the ilium; report of a case. J Bone Joint Surg Am 29(2):517–522PubMed
35.
Zurück zum Zitat Banerji S et al (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144(4):789–801CrossRefPubMedPubMedCentral Banerji S et al (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144(4):789–801CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Situma M et al An aggressive lymphatic malformation (Gorhamʼs disease) leading to death of a child. J Pediatr Surg 48(1):239–242 Situma M et al An aggressive lymphatic malformation (Gorhamʼs disease) leading to death of a child. J Pediatr Surg 48(1):239–242
39.
Zurück zum Zitat Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460–476CrossRefPubMed Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460–476CrossRefPubMed
40.
Zurück zum Zitat Huber S et al (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 71(8):771–777CrossRefPubMed Huber S et al (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 71(8):771–777CrossRefPubMed
41.
Zurück zum Zitat Kärpänen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20(9):1462–1472CrossRefPubMed Kärpänen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20(9):1462–1472CrossRefPubMed
Metadaten
Titel
Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion
verfasst von
Maria José Franco-Barrera
Maria Guadalupe Zavala-Cerna
Georgina Aguilar-Portillo
Diana Brisa Sánchez-Gomez
Olivia Torres-Bugarin
Miguel Angel Franco-Barrera
Carlos Manuel Roa-Encarnacion
Publikationsdatum
21.12.2016
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2017
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-016-8594-z

Weitere Artikel der Ausgabe 1/2017

Clinical Reviews in Allergy & Immunology 1/2017 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.